Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
AD     Remove this Ad

JAGSONPAL PHARMACEUTICALS Last 5 Year EBIT Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 130.80-12.8930.8120.29125.46

What is the latest EBIT Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest EBIT Growth ratio of JAGSONPAL PHARMACEUTICALS is 130.80 based on Mar2025 Standalone results.
Year EBIT Growth
Mar2025130.80
Mar2024-12.89
Mar202330.81
Mar202220.29
Mar2021125.46

How is EBIT Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 130.8
Positive
Mar2024 -12.89
Negative
Mar2023 30.81
51.85
Mar2022 20.29
-83.83
Mar2021 125.46 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare EBIT Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,229.1 Cr 0.4% 6.4% -17.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

0.4%

6.4%

-17.2%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses